Viatris 2023 Sustainability Report: Advocating for Patients
NORTHAMPTON, MA / ACCESSWIRE / September 12, 2024 / With people at the heart of our mission, Viatris is committed to representing and capturing the diverse voices of patients and caregivers and joining together for advocacy. As both a caretaker and a caregiver, people often experience a lack of power and limited access to information at a time when they may be at their most vulnerable. We work with many patient advocacy organizations to help provide patients and caregivers with access to information, grow their knowledge and leverage the power of their collective voice to raise awareness. Together with patient organizations and academia, we engage in education, research, sponsorships, awareness events and policy efforts with the goal to empower patients.
In 2023, this included:
Collaborated with Allergy & Anaphylaxis Australia on awareness campaigns, patient education and resources to help ensure familiarity with how and when to use epinephrine auto-injectors. We also collaborate with the Australian Society of Clinical Immunology (ASCIA) to promote, evaluate, and update ASCIA allergy and anaphylaxis e-training courses and online resources.
Sponsored the COPD Foundation's Lace up for Lungs campaign in the U.S., which is instrumental in advancing the organization's mission to help millions of people live longer and healthier lives by advancing research, advocacy and awareness to stop COPD and related lung diseases
Participated in and sponsoring the Cystic Fibrosis Foundation's annual Corporate Cup. More than a dozen colleagues took part in recreation and sporting events between area companies, while raising awareness and money to support the foundation.
Supported our longtime U.S.-based partner the Boomer Esiason Foundation to provide education and resources to families affected by cystic fibrosis and the organization's BEF Financial Hardship Fund, which provides a temporary source of funding for families during a time of unexpected adversity or emergency
Partnered with several multiple sclerosis (MS) advocacy associations, including the Multiple Sclerosis Association of America, the National MS Society and others to provide educational resources and support for people living with this autoimmune disease
Collaborated with patients' organizations and medical societies to create the MyHealthMyLife website to support patients group to provide additional resources on diseases awareness
Supported long-term partner Brazilian Association of Family, Friends and People with Affective Disorders (ABRATA) on several initiatives including disease awareness and advocacy
Partnered with the Active Citizen Network (ACN), which supports several regional and local activities on European Patients' Rights Day to strengthen patients' voice in shaping and influencing health policies focusing on the healthcare workforce crisis
Participated in the working group of Gravitate Health, a publicprivate partnership with 40 members from Europe and the U.S., which works to equip and empower people with digital information tools that make them confident, active and responsive in their patient journey
View the full 2023 Sustainability Report.

View additional multimedia and more ESG storytelling from Viatris on 3blmedia.com.
Contact Info:
Spokesperson: Viatris
Website: https://www.3blmedia.com/profiles/viatris
Email: [email protected]
SOURCE: Viatris
View the original press release on accesswire.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Volkswagen plans to close four German plants by 2034, report says
- D. Boral Capital to Sponsor Japan Go IPO Summit 2026 in Tokyo
- Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
Create E-mail Alert Related Categories
ACCESS Newswire, Press ReleasesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share